Lightspeed Management Company L.L.C. Acquires Shares of 8,160,734 Personalis, Inc. (NASDAQ:PSNL)

Lightspeed Management Company L.L.C. acquired a new position in Personalis, Inc. (NASDAQ:PSNL - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 8,160,734 shares of the company's stock, valued at approximately $47,169,000. Personalis accounts for 13.2% of Lightspeed Management Company L.L.C.'s holdings, making the stock its 4th largest position. Lightspeed Management Company L.L.C. owned approximately 11.55% of Personalis as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of PSNL. JPMorgan Chase & Co. increased its holdings in shares of Personalis by 2,827.0% in the fourth quarter. JPMorgan Chase & Co. now owns 5,854 shares of the company's stock worth $34,000 after buying an additional 5,654 shares during the period. Olympiad Research LP bought a new stake in shares of Personalis in the fourth quarter worth about $59,000. Alpine Global Management LLC bought a new stake in shares of Personalis in the fourth quarter worth about $60,000. SG Americas Securities LLC bought a new stake in shares of Personalis in the fourth quarter worth about $63,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Personalis in the fourth quarter worth about $64,000. Hedge funds and other institutional investors own 61.91% of the company's stock.

Wall Street Analyst Weigh In

PSNL has been the topic of several recent analyst reports. Craig Hallum initiated coverage on Personalis in a research note on Monday, March 17th. They issued a "buy" rating and a $8.00 target price on the stock. HC Wainwright raised their target price on Personalis from $8.00 to $9.00 and gave the stock a "buy" rating in a research note on Wednesday, May 7th. Needham & Company LLC reissued a "buy" rating and issued a $7.00 target price on shares of Personalis in a research note on Thursday, April 10th. Finally, Guggenheim started coverage on Personalis in a research note on Thursday. They issued a "buy" rating and a $6.00 target price on the stock. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $7.67.

Personalis Price Performance

NASDAQ PSNL traded up $0.06 during mid-day trading on Friday, reaching $4.95. The stock had a trading volume of 425,835 shares, compared to its average volume of 1,009,845. Personalis, Inc. has a 1 year low of $1.14 and a 1 year high of $7.20. The stock has a market cap of $437.21 million, a PE ratio of -2.95 and a beta of 1.83. The company has a fifty day moving average price of $3.76 and a 200 day moving average price of $4.46.

Personalis (NASDAQ:PSNL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported ($0.18) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.05. Personalis had a negative net margin of 104.52% and a negative return on equity of 66.07%. The company had revenue of $20.61 million during the quarter, compared to analyst estimates of $17.41 million. As a group, equities research analysts expect that Personalis, Inc. will post -1.4 earnings per share for the current year.

Personalis Profile

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.